Full-Time

Lab Phlebotomist

Posted on 1/28/2026

Tennessee Oncology

Tennessee Oncology

501-1,000 employees

Community-based cancer care with clinical research

No salary listed

Springfield, TN, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Requirements
  • Excellent phlebotomy skills
  • Outpatient facility or physician office experience
  • Phlebotomist/Medical Assistant with 2 years of clinical lab experience preferred
  • One year phlebotomy preferred.
  • Phlebotomy certification is preferred but not required
  • High school diploma required.
Responsibilities
  • Demonstrates ability to perform clean venipunctures.
  • Demonstrates ability to perform capillary collections.
  • Follows proper guidelines for safe handling of blood, body fluids and hazardous chemicals.
  • Demonstrates knowledge of procedures and practices
  • Demonstrates knowledge of ongoing quality assurance activities in the office and documents breaches of quality as they occur.
  • Maintains appropriate inventory levels of reagents and supplies.
  • Be capable of identifying problems that may adversely affect test performance or reporting of test results and either must correct the problems or immediately notify Clinic Operations Manager and Clinical Laboratory Operations Manager.
  • Must be able to document all corrective actions taken when test systems deviate from laboratory’s established performance specifications.
  • Be able to document in charts for “lab only” visits.
  • Have complete understanding of LIS; which includes ordering test, rejecting test, locating and printing result reports.
  • Other duties as assigned.

Tennessee Oncology runs a large network of community-based cancer care with a strong clinical-trial program. It delivers cancer treatment at local clinics, including on-site chemotherapy, and uses molecular diagnostics to tailor therapies to each patient’s cancer. The organization supports patients with its in-house Park Pharmacy, which stocks oncology and hematology medications and handles insurance, prior authorizations, co-pays, and 24/7 pharmacist access. It differentiates itself by combining extensive community-based care with a sizable research network and a partnership with OneOncology, enabling broad access to trials and advanced care at convenient locations. The goal is to provide high-quality cancer care and access to clinical research close to patients’ homes.

Company Size

501-1,000

Company Stage

Debt Financing

Total Funding

$98.3M

Headquarters

Nashville, Tennessee

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Opened Johnson City clinic November 5, 2024, staffed by Drs. Maatouk and Lord.
  • Partnered with OncoveryCare post-$4.5M funding for survivorship care model.
  • Launched rural telehealth program in Dickson and Robertson Counties.

What critics are saying

  • Ascension's Drs. Waynick and Mitchell steal Tullahoma patients within 6-12 months.
  • SOPHiA GENETICS rivals erode precision medicine edge in 12-24 months.
  • One Oncology acquires practices, forcing Tennessee Oncology sale in 12-18 months.

What makes Tennessee Oncology unique

  • Tennessee Oncology integrates medical oncology, radiation oncology, and imaging at Tullahoma center.
  • Appointed Dr. Casey Chollet-Lipscomb as Chief Medical Officer on March 10, 2025.
  • Expanded SOPHiA GENETICS partnership for precision medicine across 36 clinics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Flexible Work Hours

Company News

Tennessee Oncology
Sep 24th, 2025
Tennessee Oncology Breaks Ground on State-of-the-Art Medical Center in Tullahoma

Tennessee Oncology breaks ground on state-of-the-art Medical Center in Tullahoma. Tennessee Oncology recently broke ground a new state-of-the-art medical center in Tullahoma. Located on a three-acre campus, the 33,000 square foot center will bring together medical oncology, radiation oncology, and imaging services - offering patients comprehensive, coordinated cancer care in one location, close to home. "The official groundbreaking of the Tullahoma Medical Center is more than the start of construction - it is a continuation of a mission, a vision, and a legacy of compassionate care for the Tullahoma community," said Natalie Dickson, MD, President and CEO of Tennessee Oncology. "This new facility represents a bold step forward for Tullahoma. Together, with Dr. Ryan Carr, Dr. Nnamdi Eze, Dr. John Phillips, Dr. Brian Schlick, and Dr. Mark Sittig, we are laying the foundation for something that will make a lasting impact. This center will not only provide critical care to patients, but it will also stand as a symbol of hope, healing, and the enduring strength of this community." The Tullahoma Medical Center is a continuation of the incredible legacy of Dr. Mainuddin Ahmed and Dr. Adil Mohyuddin, whose commitment to oncology care in the Tullahoma region laid the foundation for the care Tnoncology provide patients today. This new medical center represents the heart of its mission at Tennessee Oncology - bringing world-class cancer care closer to the communities that need it most. Its investment in the Tullahoma Medical Center reflects its commitment to expanding access, supporting local patients, and delivering compassionate care where it matters. Tennessee Oncology extends a sincere thank-you to Jason Quick, the Tullahoma City Administrator, and Kathryn Wiseman of the Tullahoma Area Chamber of Commerce. Their dedication to the community and support of this project have been instrumental.

PR Newswire
Mar 10th, 2025
Tennessee Oncology Appoints Dr. Casey Chollet-Lipscomb As Chief Medical Officer

NASHVILLE, Tenn., March 10, 2025 /PRNewswire/ -- Tennessee Oncology, a nationally recognized independent oncology practice that treats nearly half of the cancer patients in the state across 36 clinics, is pleased to announce the appointment of Casey Chollet-Lipscomb, MD, as its new Chief Medical Officer

PR Newswire
Dec 3rd, 2024
Oneoncology Partner Practice Investigators To Present 26 Abstracts At Ash Annual Meeting

NASHVILLE, Tenn., Dec. 3, 2024 /PRNewswire/ -- OneOncology, a physician-led platform dedicated to advancing independent community oncology practices, and the OneOncology Research Network (OneR), its clinical research site management organization, proudly recognize the outstanding research contributions of its partner practice investigators from The Cancer and Hematology Centers in Michigan, New York Cancer Blood Specialists and Tennessee Oncology, who will showcase a total of 26 oral and poster presentations at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 7–10, 2024

Impact Newswire
Nov 22nd, 2024
SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

SOPHiA GENETICS announces expanded partnership with Tennessee Oncology.

PR Newswire
Nov 5th, 2024
Tennessee Oncology Expands Cancer Care With New Clinic In Johnson City

NASHVILLE, Tenn., Nov. 5, 2024 /PRNewswire/ -- Tennessee Oncology, a nationally recognized independent oncology practice that cares for nearly half of Tennessee's cancer patients across 36 locations, proudly announces the opening of its new cancer care center in Johnson City. The clinic will be staffed by Jamal Maatouk, MD, Teresa Lord, MD, and a dedicated 30-member care team. "Expanding access to cancer care in Johnson City enables Tennessee Oncology to deliver world-class cancer treatment to the Tri-Cities region, eliminating the need for patients to travel long distances for the same high-quality care as they would receive in Nashville or Chattanooga," said Natalie Dickson, MD, President and Chief Executive Officer of Tennessee Oncology. "We are thrilled to welcome Dr. Maatouk and Dr

INACTIVE